| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
McGill University Cancer Research Unit, Montreal, Quebec, Canada
An enzymatic method for the estimation of the concentration of 1-ß-D-arabinofuranosylcytosine (ara-C) in biological fluid has been developed. The method consists of the phosphorylation of ara-C with ATP-
-32P in the presence of deoxycytidine kinase and Mg++ and subsequent isolation of the 5'-monophosphate of ara-C (ara-CMP-
-32P) by thin-layer chromatography on diethylaminoethyl-cellulose. This method requires only 3 hr to complete and can detect concentrations of ara-C in the plasma as low as 2.5
M. With this enzymatic method the half-life of ara-C in the plasma was estimated to be 15 min in a patient with acute leukemia who received a continuous i.v. infusion of ara-C.
Since for most nucleoside analogs the active inhibitor is a phosphorylated derivative, the enzymatic method can be used as an additional procedure for the screening of potential antitumor nucleosides.
1 Supported by the National Cancer Institute of Canada.
2 Recipient of USPHS International Fellowship 1F05 TWO 1731-01. Present address: Laboratory of Molecular Embryology, Naples, Italy.
Received 9/28/71. Accepted 11/ 4/71.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |